Annual CFF
$1.34 M
-$3.90 M-74.49%
01 December 2023
Summary:
Lipella Pharmaceuticals Common Stock annual cash flow from financing activities is currently $1.34 million, with the most recent change of -$3.90 million (-74.49%) on 01 December 2023. During the last 3 years, it has risen by +$727.30 thousand (+119.37%). LIPO annual CFF is now -74.49% below its all-time high of $5.24 million, reached on 31 December 2022.LIPO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$820.30 K
+$820.30 K+100.00%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock quarterly cash flow from financing activities is currently $820.30 thousand, with the most recent change of +$820.30 thousand (+100.00%) on 01 September 2024. Over the past year, it has dropped by -$791.30 thousand (-49.10%). LIPO quarterly CFF is now -84.34% below its all-time high of $5.24 million, reached on 31 December 2022.LIPO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$2.63 M
+$820.30 K+45.28%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock TTM cash flow from financing activities is currently $2.63 million, with the most recent change of +$820.30 thousand (+45.28%) on 01 September 2024. Over the past year, it has increased by +$1.30 million (+96.91%). LIPO TTM CFF is now -49.76% below its all-time high of $5.24 million, reached on 31 December 2022.LIPO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIPO Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -49.1% | +96.9% |
| 3 y3 years | +119.4% | +10000.0% | +25.5% |
| 5 y5 years | - | - | - |
LIPO Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -74.5% | +119.4% | -84.3% | +428.1% | -49.8% | >+9999.0% |
| 5 y | 5 years | -74.5% | +119.4% | -84.3% | +428.1% | -49.8% | >+9999.0% |
| alltime | all time | -74.5% | +119.4% | -84.3% | +428.1% | -49.8% | >+9999.0% |
Lipella Pharmaceuticals Common Stock Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $820.30 K(>+9900.0%) | $2.63 M(+45.3%) |
| June 2024 | - | $0.00(-100.0%) | $1.81 M(+16.0%) |
| Mar 2024 | - | $200.00 K(-87.6%) | $1.56 M(+16.8%) |
| Dec 2023 | $1.34 M(-74.5%) | $1.61 M(>+9900.0%) | $1.34 M(-73.1%) |
| Sept 2023 | - | $0.00(-100.0%) | $4.96 M(0.0%) |
| June 2023 | - | -$250.00 K(+900.0%) | $4.96 M(-4.8%) |
| Mar 2023 | - | -$25.00 K(-100.5%) | $5.21 M(-0.5%) |
| Dec 2022 | $5.24 M | $5.24 M(>+9900.0%) | $5.24 M(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $0.00(0.0%) | $2200.00(+633.3%) |
| June 2022 | - | $0.00(0.0%) | $300.00(-100.0%) |
| Mar 2022 | - | $0.00(-100.0%) | $639.30 K(-69.5%) |
| Dec 2021 | $2.10 M(+244.1%) | - | - |
| Dec 2021 | - | $2200.00(-215.8%) | $2.10 M(+0.1%) |
| Sept 2021 | - | -$1900.00(-100.3%) | $2.09 M(-0.1%) |
| June 2021 | - | $639.00 K(-56.2%) | $2.10 M(+43.8%) |
| Mar 2021 | - | $1.46 M | $1.46 M |
| Dec 2020 | $609.30 K | - | - |
FAQ
- What is Lipella Pharmaceuticals Common Stock annual cash flow from financing activities?
- What is the all time high annual CFF for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly CFF year-on-year change?
- What is Lipella Pharmaceuticals Common Stock TTM cash flow from financing activities?
- What is the all time high TTM CFF for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock TTM CFF year-on-year change?
What is Lipella Pharmaceuticals Common Stock annual cash flow from financing activities?
The current annual CFF of LIPO is $1.34 M
What is the all time high annual CFF for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high annual cash flow from financing activities is $5.24 M
What is Lipella Pharmaceuticals Common Stock quarterly cash flow from financing activities?
The current quarterly CFF of LIPO is $820.30 K
What is the all time high quarterly CFF for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high quarterly cash flow from financing activities is $5.24 M
What is Lipella Pharmaceuticals Common Stock quarterly CFF year-on-year change?
Over the past year, LIPO quarterly cash flow from financing activities has changed by -$791.30 K (-49.10%)
What is Lipella Pharmaceuticals Common Stock TTM cash flow from financing activities?
The current TTM CFF of LIPO is $2.63 M
What is the all time high TTM CFF for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high TTM cash flow from financing activities is $5.24 M
What is Lipella Pharmaceuticals Common Stock TTM CFF year-on-year change?
Over the past year, LIPO TTM cash flow from financing activities has changed by +$1.30 M (+96.91%)